Takeda Pharmaceutical TAK
NYSE TAK
$18.19 -0.33 (-1.78%)
At close: Sep 30, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Current Deferred Revenue (2017 - 2018)

Updated

Takeda Pharmaceutical (TAK) recorded Current Deferred Revenue of $100,000 in the year ended Dec 31, 2018, down 97.1% from $3.5 million a year earlier.

Analysis

Takeda Pharmaceutical (TAK) Current Deferred Revenue (2017 - 2018) Analysis & Trends

  • Per Business Quant data, TAK's Current Deferred Revenue was $3.5 million in the year ended Dec 31, 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 100,000.00
Dec 31, 2017 3.50 Mn
API Access

Takeda Pharmaceutical Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TAK&period=max&api_key=YOUR_API_KEY